Phage choice, isolation, and preparation for phage therapy

JJ Gill, P Hyman - Current pharmaceutical biotechnology, 2010 - ingentaconnect.com
Phage therapy is the use of bacteriophages—viruses that use bacteria as their host cells—
as biocontrol agents of bacteria. Currently, phage therapy is garnering renewed interest as …

The factors affecting effectiveness of treatment in phages therapy

MH Ly-Chatain - Frontiers in microbiology, 2014 - frontiersin.org
In recent years, the use of lytic bacteriophages as antimicrobial agents controlling
pathogenic bacteria has appeared as a promising new alternative strategy in the face of …

Systematic discovery of antiphage defense systems in the microbial pangenome

S Doron, S Melamed, G Ofir, A Leavitt, A Lopatina… - Science, 2018 - science.org
INTRODUCTION Bacteria and archaea are frequently attacked by viruses (phages) and as a
result have developed multiple, sophisticated lines of active defense that can collectively be …

Prokaryotic viperins produce diverse antiviral molecules

A Bernheim, A Millman, G Ofir, G Meitav, C Avraham… - Nature, 2021 - nature.com
Viperin is an interferon-induced cellular protein that is conserved in animals. It has
previously been shown to inhibit the replication of multiple viruses by producing the …

Identification and classification of antiviral defence systems in bacteria and archaea with PADLOC reveals new system types

LJ Payne, TC Todeschini, Y Wu, BJ Perry… - Nucleic acids …, 2021 - academic.oup.com
To provide protection against viral infection and limit the uptake of mobile genetic elements,
bacteria and archaea have evolved many diverse defence systems. The discovery and …

DISARM is a widespread bacterial defence system with broad anti-phage activities

G Ofir, S Melamed, H Sberro, Z Mukamel… - Nature …, 2018 - nature.com
The evolutionary pressure imposed by phage predation on bacteria and archaea has
resulted in the development of effective anti-phage defence mechanisms, including …

Bacteriophage procurement for therapeutic purposes

B Weber-Dąbrowska, E Jończyk-Matysiak… - Frontiers in …, 2016 - frontiersin.org
Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only
bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a …

Factors determining phage stability/activity: challenges in practical phage application

E Jończyk-Matysiak, N Łodej, D Kula… - Expert review of anti …, 2019 - Taylor & Francis
Introduction: Phages consist of nucleic acids and proteins that may lose their activity under
different physico-chemical conditions. The production process of phage formulations may …

Control of bacterial cell wall autolysins by peptidoglycan crosslinking mode

L Alvarez, SB Hernandez, G Torrens, AI Weaver… - Nature …, 2024 - nature.com
To withstand their internal turgor pressure and external threats, most bacteria have a
protective peptidoglycan (PG) cell wall. The growth of this PG polymer relies on autolysins …

Bacteriophage therapy: advances in formulation strategies and human clinical trials

D Vandenheuvel, R Lavigne… - Annual review of …, 2015 - annualreviews.org
Recently, a number of phage therapy phase I and II safety trials have been concluded,
showing no notable safety concerns associated with the use of phage. Though hurdles for …